Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy
MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2341

Journal of Vaccines & Vaccination received 2341 citations as per Google Scholar report

Journal of Vaccines & Vaccination
Journal of Vaccines & Vaccination peer review process verified at publons
Journal of Vaccines & Vaccination
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

Journal total citations count 2341
Journal impact factor 2.87
Journal 5 years impact factor 3.73
Journal cite score 4.69
Journal h-index 24
Flyer image
Important citations

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and

Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries.

Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period

Systematic review of dengue vaccine efficacy

Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial.

Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study.

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials.

Tackling dengue fever: Current status and challenges

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).

Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis.

Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials.

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety.

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies

Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil